메뉴 건너뛰기




Volumn 9, Issue 1, 2016, Pages

Targeting histone methylation for cancer therapy: Enzymes, inhibitors, biological activity and perspectives

Author keywords

Cancer therapeutics; Enzyme inhibitor; Histone demethylase; Histone lysine methyltransferase; Histone methylation; Protein arginine methyltransferase

Indexed keywords

1 [3 [[5 (4 AMINO 5 BROMO 7H PYRROLO[2,3 D]PYRIMIDIN 7 YL) 3,4 DIHYDROXYTETRAHYDRO 2 FURFURYL](ISOPROPYL)AMINO]PROPYL] 3 (4 TERT BUTYLPHENYL)UREA; ARGININE; ENASIDENIB; EPZ 004777; GSK 126; GSK 2879552; GSK 690; HISTONE; HISTONE DEACETYLASE INHIBITOR; HISTONE LYSINE METHYLTRANSFERASE; HISTONE LYSINE METHYLTRANSFERASE INHIBITOR; HISTONE METHYLTRANSFERASE; ISOCITRATE DEHYDROGENASE; LYSINE; LYSINE SPECIFIC DEMETHYLASE 1; MIXED LINEAGE LEUKEMIA PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN INHIBITOR; MONOAMINE OXIDASE INHIBITOR; N (1 BENZYL 4 PIPERIDINYL) 2 (HEXAHYDRO 4 METHYL 1H 1,4 DIAZEPIN 1 YL) 6,7 DIMETHOXY 4 QUINAZOLINAMINE; N CYCLOPROPYL 4 (3 THIENYL) 3 [[[[3 (TRIFLUOROMETHYL)PHENYL]AMINO]CARBONYL]AMINO]BENZENESULFONAMIDE; N [2 CYCLOHEXYLAMINO 1 (2 METHYLPHENYL) 2 OXOETHYL] N (3 FLUOROPHENYL) 2 METHYL 1H IMIDAZOLE 1 ACETAMIDE; OXYGENASE; PINOMETOSTAT; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN INHIBITOR; SP 2509; TAZEMETOSTAT; TRANYLCYPROMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZPI 169; ENZYME INHIBITOR; METHYLTRANSFERASE;

EID: 84975789841     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/s13045-016-0279-9     Document Type: Review
Times cited : (123)

References (200)
  • 1
    • 33847065486 scopus 로고    scopus 로고
    • The epigenomics of cancer
    • 1:CAS:528:DC%2BD2sXis12ju7k%3D 17320506 3894624
    • Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128(4):683-92.
    • (2007) Cell , vol.128 , Issue.4 , pp. 683-692
    • Jones, P.A.1    Baylin, S.B.2
  • 2
    • 33847076849 scopus 로고    scopus 로고
    • Chromatin modifications and their function
    • 1:CAS:528:DC%2BD2sXis12ju7Y%3D 17320507
    • Kouzarides T. Chromatin modifications and their function. Cell. 2007;128(4):693-705.
    • (2007) Cell , vol.128 , Issue.4 , pp. 693-705
    • Kouzarides, T.1
  • 3
    • 30344477367 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
    • 1:CAS:528:DC%2BD28Xht1GgsA%3D%3D 16397526
    • Minucci S, Pelicci PG. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer. 2006;6(1):38-51.
    • (2006) Nat Rev Cancer , vol.6 , Issue.1 , pp. 38-51
    • Minucci, S.1    Pelicci, P.G.2
  • 4
    • 69949148388 scopus 로고    scopus 로고
    • Protein methyltransferases as a target class for drug discovery
    • 1:CAS:528:DC%2BD1MXhtVKmsrvI 19721445
    • Copeland RA, Solomon ME, Richon VM. Protein methyltransferases as a target class for drug discovery. Nat Rev Drug Discov. 2009;8(9):724-32.
    • (2009) Nat Rev Drug Discov , vol.8 , Issue.9 , pp. 724-732
    • Copeland, R.A.1    Solomon, M.E.2    Richon, V.M.3
  • 5
    • 0242522928 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors
    • 1:CAS:528:DC%2BD3sXosVCktbg%3D 14613312
    • Miller TA, Witter DJ, Belvedere S. Histone deacetylase inhibitors. J Med Chem. 2003;46(24):5097-116.
    • (2003) J Med Chem , vol.46 , Issue.24 , pp. 5097-5116
    • Miller, T.A.1    Witter, D.J.2    Belvedere, S.3
  • 6
    • 11844278521 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors
    • 1:CAS:528:DC%2BD2MXjtFyqtA%3D%3D 15642405
    • Monneret C. Histone deacetylase inhibitors. Eur J Med Chem. 2005;40(1):1-13.
    • (2005) Eur J Med Chem , vol.40 , Issue.1 , pp. 1-13
    • Monneret, C.1
  • 7
    • 84924104310 scopus 로고    scopus 로고
    • C-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors
    • 25477070 4261569
    • Zheng Z, Cheng S, Wu W, Wang L, Zhao Y, Shen Y, et al. c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors. J Hematol Oncol. 2014;7:88.
    • (2014) J Hematol Oncol , vol.7 , pp. 88
    • Zheng, Z.1    Cheng, S.2    Wu, W.3    Wang, L.4    Zhao, Y.5    Shen, Y.6    Janin, A.7    Zhao, W.L.8
  • 8
    • 35848951163 scopus 로고    scopus 로고
    • Covalent modifications of histones during development and disease pathogenesis
    • 1:CAS:528:DC%2BD2sXht1Kjs7jM 17984963
    • Bhaumik SR, Smith E, Shilatifard A. Covalent modifications of histones during development and disease pathogenesis. Nat Struct Mol Biol. 2007;14(11):1008-16.
    • (2007) Nat Struct Mol Biol , vol.14 , Issue.11 , pp. 1008-1016
    • Bhaumik, S.R.1    Smith, E.2    Shilatifard, A.3
  • 9
    • 20544461679 scopus 로고    scopus 로고
    • Structural and sequence motifs of protein (histone) methylation enzymes
    • 1:CAS:528:DC%2BD2MXlslCku7s%3D 15869391 2733851
    • Cheng X, Collins RE, Zhang X. Structural and sequence motifs of protein (histone) methylation enzymes. Annu Rev Biophys Biomol Struct. 2005;34:267-94.
    • (2005) Annu Rev Biophys Biomol Struct , vol.34 , pp. 267-294
    • Cheng, X.1    Collins, R.E.2    Zhang, X.3
  • 10
    • 0038374971 scopus 로고    scopus 로고
    • Many paths to methyltransfer: A chronicle of convergence
    • 1:CAS:528:DC%2BD3sXkvVCmsrw%3D 12826405 2758044
    • Schubert HL, Blumenthal RM, Cheng X. Many paths to methyltransfer: a chronicle of convergence. Trends Biochem Sci. 2003;28(6):329-35.
    • (2003) Trends Biochem Sci , vol.28 , Issue.6 , pp. 329-335
    • Schubert, H.L.1    Blumenthal, R.M.2    Cheng, X.3
  • 11
    • 84954396146 scopus 로고    scopus 로고
    • Histone demethylases in chromatin biology and beyond
    • 1:CAS:528:DC%2BC2MXhvVajsLvJ 26564907 4687429
    • Dimitrova E, Turberfield AH, Klose RJ. Histone demethylases in chromatin biology and beyond. EMBO Rep. 2015;16(12):1620-39.
    • (2015) EMBO Rep , vol.16 , Issue.12 , pp. 1620-1639
    • Dimitrova, E.1    Turberfield, A.H.2    Klose, R.J.3
  • 12
    • 84889573275 scopus 로고    scopus 로고
    • Histone lysine demethylases as targets for anticancer therapy
    • 1:CAS:528:DC%2BC3sXhslygtrrP 24232376
    • Hojfeldt JW, Agger K, Helin K. Histone lysine demethylases as targets for anticancer therapy. Nat Rev Drug Discov. 2013;12(12):917-30.
    • (2013) Nat Rev Drug Discov , vol.12 , Issue.12 , pp. 917-930
    • Hojfeldt, J.W.1    Agger, K.2    Helin, K.3
  • 13
    • 43249102851 scopus 로고    scopus 로고
    • Erasing the methyl mark: Histone demethylases at the center of cellular differentiation and disease
    • 1:CAS:528:DC%2BD1cXlslCqsr0%3D 18451103 2732404
    • Cloos PA, Christensen J, Agger K, Helin K. Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev. 2008;22(9):1115-40.
    • (2008) Genes Dev , vol.22 , Issue.9 , pp. 1115-1140
    • Cloos, P.A.1    Christensen, J.2    Agger, K.3    Helin, K.4
  • 14
    • 51949111451 scopus 로고    scopus 로고
    • Chemical probes for histone-modifying enzymes
    • 1:CAS:528:DC%2BD1cXhtFamtbrL 18800048 2908280
    • Cole PA. Chemical probes for histone-modifying enzymes. Nat Chem Biol. 2008;4(10):590-7.
    • (2008) Nat Chem Biol , vol.4 , Issue.10 , pp. 590-597
    • Cole, P.A.1
  • 15
    • 84905254858 scopus 로고    scopus 로고
    • Epigenetic targets and drug discovery: Part 1: Histone methylation
    • 1:CAS:528:DC%2BC2cXmt1GntLo%3D 24704322
    • Liu Y, Liu K, Qin S, Xu C, Min J. Epigenetic targets and drug discovery: part 1: histone methylation. Pharmacol Ther. 2014;143(3):275-94.
    • (2014) Pharmacol Ther , vol.143 , Issue.3 , pp. 275-294
    • Liu, Y.1    Liu, K.2    Qin, S.3    Xu, C.4    Min, J.5
  • 16
    • 84930212511 scopus 로고    scopus 로고
    • Epigenetic targets and drug discovery Part 2: Histone demethylation and DNA methylation
    • 1:CAS:528:DC%2BC2MXmsFSiu7o%3D 25857453
    • Liu K, Liu Y, Lau JL, Min J. Epigenetic targets and drug discovery Part 2: Histone demethylation and DNA methylation. Pharmacol Ther. 2015;151:121-40.
    • (2015) Pharmacol Ther , vol.151 , pp. 121-140
    • Liu, K.1    Liu, Y.2    Lau, J.L.3    Min, J.4
  • 17
    • 84928383804 scopus 로고    scopus 로고
    • Targeting histone lysine methylation in cancer
    • 1:CAS:528:DC%2BC2MXht1KrtL4%3D 25578037
    • McGrath J, Trojer P. Targeting histone lysine methylation in cancer. Pharmacol Ther. 2015;150:1-22.
    • (2015) Pharmacol Ther , vol.150 , pp. 1-22
    • McGrath, J.1    Trojer, P.2
  • 19
    • 23944509075 scopus 로고    scopus 로고
    • The SET-domain protein superfamily: Protein lysine methyltransferases
    • 16086857 1273623
    • Dillon SC, Zhang X, Trievel RC, Cheng X. The SET-domain protein superfamily: protein lysine methyltransferases. Genome Biol. 2005;6(8):227.
    • (2005) Genome Biol , vol.6 , Issue.8 , pp. 227
    • Dillon, S.C.1    Zhang, X.2    Trievel, R.C.3    Cheng, X.4
  • 20
    • 0344837759 scopus 로고    scopus 로고
    • Structure of the catalytic domain of human DOT1L, a non-SET domain nucleosomal histone methyltransferase
    • 1:CAS:528:DC%2BD3sXitFyku70%3D 12628190
    • Min J, Feng Q, Li Z, Zhang Y, Xu RM. Structure of the catalytic domain of human DOT1L, a non-SET domain nucleosomal histone methyltransferase. Cell. 2003;112(5):711-23.
    • (2003) Cell , vol.112 , Issue.5 , pp. 711-723
    • Min, J.1    Feng, Q.2    Li, Z.3    Zhang, Y.4    Xu, R.M.5
  • 23
    • 11144332565 scopus 로고    scopus 로고
    • Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
    • 1:CAS:528:DC%2BD2MXltlSitg%3D%3D 15620353
    • Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell. 2004;119(7):941-53.
    • (2004) Cell , vol.119 , Issue.7 , pp. 941-953
    • Shi, Y.1    Lan, F.2    Matson, C.3    Mulligan, P.4    Whetstine, J.R.5    Cole, P.A.6    Casero, R.A.7
  • 24
    • 34547132094 scopus 로고    scopus 로고
    • Structural basis of LSD1-CoREST selectivity in histone H3 recognition
    • 1:CAS:528:DC%2BD2sXnsFWntr0%3D 17537733
    • Forneris F, Binda C, Adamo A, Battaglioli E, Mattevi A. Structural basis of LSD1-CoREST selectivity in histone H3 recognition. J Biol Chem. 2007;282(28):20070-4.
    • (2007) J Biol Chem , vol.282 , Issue.28 , pp. 20070-20074
    • Forneris, F.1    Binda, C.2    Adamo, A.3    Battaglioli, E.4    Mattevi, A.5
  • 25
    • 78049286684 scopus 로고    scopus 로고
    • Histone demethylases in development and disease
    • 1:CAS:528:DC%2BC3cXhtlKhs7rF 20863703
    • Pedersen MT, Helin K. Histone demethylases in development and disease. Trends Cell Biol. 2010;20(11):662-71.
    • (2010) Trends Cell Biol , vol.20 , Issue.11 , pp. 662-671
    • Pedersen, M.T.1    Helin, K.2
  • 26
    • 84934966421 scopus 로고    scopus 로고
    • Advances in the development of histone lysine demethylase inhibitors
    • 1:CAS:528:DC%2BC2MXpt1Slt7o%3D 26057211
    • Maes T, Carceller E, Salas J, Ortega A, Buesa C. Advances in the development of histone lysine demethylase inhibitors. Curr Opin Pharmacol. 2015;23:52-60.
    • (2015) Curr Opin Pharmacol , vol.23 , pp. 52-60
    • Maes, T.1    Carceller, E.2    Salas, J.3    Ortega, A.4    Buesa, C.5
  • 27
    • 33749576106 scopus 로고    scopus 로고
    • Histone demethylation by hydroxylation: Chemistry in action
    • 1:CAS:528:DC%2BD28XivVyitrg%3D 17163647
    • Schneider J, Shilatifard A. Histone demethylation by hydroxylation: chemistry in action. ACS Chem Biol. 2006;1(2):75-81.
    • (2006) ACS Chem Biol , vol.1 , Issue.2 , pp. 75-81
    • Schneider, J.1    Shilatifard, A.2
  • 29
    • 77449127237 scopus 로고    scopus 로고
    • Enzymatic and structural insights for substrate specificity of a family of jumonji histone lysine demethylases
    • 1:CAS:528:DC%2BD1MXhsFyhsL3J 20023638
    • Horton JR, Upadhyay AK, Qi HH, Zhang X, Shi Y, Cheng X. Enzymatic and structural insights for substrate specificity of a family of jumonji histone lysine demethylases. Nat Struct Mol Biol. 2010;17(1):38-43.
    • (2010) Nat Struct Mol Biol , vol.17 , Issue.1 , pp. 38-43
    • Horton, J.R.1    Upadhyay, A.K.2    Qi, H.H.3    Zhang, X.4    Shi, Y.5    Cheng, X.6
  • 31
    • 0037172665 scopus 로고    scopus 로고
    • Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain
    • 1:CAS:528:DC%2BD38XlsVyjtLY%3D 12123582
    • Feng Q, Wang H, Ng HH, Erdjument-Bromage H, Tempst P, Struhl K, et al. Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain. Curr Biol. 2002;12(12):1052-8.
    • (2002) Curr Biol , vol.12 , Issue.12 , pp. 1052-1058
    • Feng, Q.1    Wang, H.2    Ng, H.H.3    Erdjument-Bromage, H.4    Tempst, P.5    Struhl, K.6    Zhang, Y.7
  • 34
    • 33846522525 scopus 로고    scopus 로고
    • The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling
    • 1:CAS:528:DC%2BD2sXotVWqsg%3D%3D 17135274
    • Bitoun E, Oliver PL, Davies KE. The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. Hum Mol Genet. 2007;16(1):92-106.
    • (2007) Hum Mol Genet , vol.16 , Issue.1 , pp. 92-106
    • Bitoun, E.1    Oliver, P.L.2    Davies, K.E.3
  • 37
    • 79959960773 scopus 로고    scopus 로고
    • The diverse functions of Dot1 and H3K79 methylation
    • 1:CAS:528:DC%2BC3MXptlSjsLY%3D 21724828 3134078
    • Nguyen AT, Zhang Y. The diverse functions of Dot1 and H3K79 methylation. Genes Dev. 2011;25(13):1345-58.
    • (2011) Genes Dev , vol.25 , Issue.13 , pp. 1345-1358
    • Nguyen, A.T.1    Zhang, Y.2
  • 38
    • 77949563562 scopus 로고    scopus 로고
    • Targeting DOT1L action and interactions in leukemia: The role of DOT1L in transformation and development
    • 1:CAS:528:DC%2BC3cXjt1Kqt78%3D 20230194
    • Barry ER, Corry GN, Rasmussen TP. Targeting DOT1L action and interactions in leukemia: the role of DOT1L in transformation and development. Expert Opin Ther Targets. 2010;14(4):405-18.
    • (2010) Expert Opin Ther Targets , vol.14 , Issue.4 , pp. 405-418
    • Barry, E.R.1    Corry, G.N.2    Rasmussen, T.P.3
  • 39
    • 82455186371 scopus 로고    scopus 로고
    • A role for DOT1L in MLL-rearranged leukemias
    • 1:CAS:528:DC%2BC3MXhsFartrzF 22126283
    • Bernt KM, Armstrong SA. A role for DOT1L in MLL-rearranged leukemias. Epigenomics. 2011;3(6):667-70.
    • (2011) Epigenomics , vol.3 , Issue.6 , pp. 667-670
    • Bernt, K.M.1    Armstrong, S.A.2
  • 40
    • 0026443594 scopus 로고
    • Silencers, silencing, and heritable transcriptional states
    • 1:CAS:528:DyaK3sXisVymt7w%3D 1480108 372887
    • Laurenson P, Rine J. Silencers, silencing, and heritable transcriptional states. Microbiol Rev. 1992;56(4):543-60.
    • (1992) Microbiol Rev , vol.56 , Issue.4 , pp. 543-560
    • Laurenson, P.1    Rine, J.2
  • 41
    • 0037077178 scopus 로고    scopus 로고
    • Dot1p modulates silencing in yeast by methylation of the nucleosome core
    • 12086673
    • van Leeuwen F, Gafken PR, Gottschling DE. Dot1p modulates silencing in yeast by methylation of the nucleosome core. Cell. 2002;109(6):745-56.
    • (2002) Cell , vol.109 , Issue.6 , pp. 745-756
    • Van Leeuwen, F.1    Gafken, P.R.2    Gottschling, D.E.3
  • 44
    • 13744259076 scopus 로고    scopus 로고
    • Characterization of the grappa gene, the Drosophila histone H3 lysine 79 methyltransferase
    • 1:CAS:528:DC%2BD2MXit1yhsrs%3D 15371351 1448877
    • Shanower GA, Muller M, Blanton JL, Honti V, Gyurkovics H, Schedl P. Characterization of the grappa gene, the Drosophila histone H3 lysine 79 methyltransferase. Genetics. 2005;169(1):173-84.
    • (2005) Genetics , vol.169 , Issue.1 , pp. 173-184
    • Shanower, G.A.1    Muller, M.2    Blanton, J.L.3    Honti, V.4    Gyurkovics, H.5    Schedl, P.6
  • 45
    • 40949103054 scopus 로고    scopus 로고
    • Changes in H3K79 methylation during preimplantation development in mice
    • 1:CAS:528:DC%2BD1cXisFSltbo%3D 18003948
    • Ooga M, Inoue A, Kageyama S, Akiyama T, Nagata M, Aoki F. Changes in H3K79 methylation during preimplantation development in mice. Biol Reprod. 2008;78(3):413-24.
    • (2008) Biol Reprod , vol.78 , Issue.3 , pp. 413-424
    • Ooga, M.1    Inoue, A.2    Kageyama, S.3    Akiyama, T.4    Nagata, M.5    Aoki, F.6
  • 47
    • 80052480322 scopus 로고    scopus 로고
    • Essential role of DOT1L in maintaining normal adult hematopoiesis
    • 1:CAS:528:DC%2BC3MXhtFWksbrI 21769133 3166961
    • Nguyen AT, He J, Taranova O, Zhang Y. Essential role of DOT1L in maintaining normal adult hematopoiesis. Cell Res. 2011;21(9):1370-3.
    • (2011) Cell Res , vol.21 , Issue.9 , pp. 1370-1373
    • Nguyen, A.T.1    He, J.2    Taranova, O.3    Zhang, Y.4
  • 50
    • 77953813886 scopus 로고    scopus 로고
    • Dot1a contains three nuclear localization signals and regulates the epithelial Na+ channel (ENaC) at multiple levels
    • 1:CAS:528:DC%2BC3cXpsVOrur8%3D 20427473 2904171
    • Reisenauer MR, Wang SW, Xia Y, Zhang W. Dot1a contains three nuclear localization signals and regulates the epithelial Na+ channel (ENaC) at multiple levels. Am J Physiol Renal Physiol. 2010;299(1):F63-76.
    • (2010) Am J Physiol Renal Physiol , vol.299 , Issue.1 , pp. F63-F76
    • Reisenauer, M.R.1    Wang, S.W.2    Xia, Y.3    Zhang, W.4
  • 51
    • 33745873838 scopus 로고    scopus 로고
    • Dot1a-AF9 complex mediates histone H3 Lys-79 hypermethylation and repression of ENaCalpha in an aldosterone-sensitive manner
    • 1:CAS:528:DC%2BD28XmtFyktLk%3D 16636056 3015183
    • Zhang W, Xia X, Reisenauer MR, Hemenway CS, Kone BC. Dot1a-AF9 complex mediates histone H3 Lys-79 hypermethylation and repression of ENaCalpha in an aldosterone-sensitive manner. J Biol Chem. 2006;281(26):18059-68.
    • (2006) J Biol Chem , vol.281 , Issue.26 , pp. 18059-18068
    • Zhang, W.1    Xia, X.2    Reisenauer, M.R.3    Hemenway, C.S.4    Kone, B.C.5
  • 52
    • 35548934558 scopus 로고    scopus 로고
    • MLL translocations, histone modifications and leukaemia stem-cell development
    • 1:CAS:528:DC%2BD2sXht1Wgsb%2FJ 17957188
    • Krivtsov AV, Armstrong SA. MLL translocations, histone modifications and leukaemia stem-cell development. Nature reviews. 2007;7(11):823-33.
    • (2007) Nature Reviews , vol.7 , Issue.11 , pp. 823-833
    • Krivtsov, A.V.1    Armstrong, S.A.2
  • 53
    • 17044413548 scopus 로고    scopus 로고
    • The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis
    • 1:CAS:528:DC%2BD2MXjtF2it7Y%3D 15826832
    • Daser A, Rabbitts TH. The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis. Semin Cancer Biol. 2005;15(3):175-88.
    • (2005) Semin Cancer Biol , vol.15 , Issue.3 , pp. 175-188
    • Daser, A.1    Rabbitts, T.H.2
  • 54
    • 67650357912 scopus 로고    scopus 로고
    • Therapeutic targeting of MLL
    • 1:CAS:528:DC%2BD1MXnslSmuro%3D 19289854 2699228
    • Liedtke M, Cleary ML. Therapeutic targeting of MLL. Blood. 2009;113(24):6061-8.
    • (2009) Blood , vol.113 , Issue.24 , pp. 6061-6068
    • Liedtke, M.1    Cleary, M.L.2
  • 56
    • 0027172909 scopus 로고
    • Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome
    • 1:CAS:528:DyaK3sXltFCmsrg%3D 8481519
    • Chen CS, Sorensen PH, Domer PH, Reaman GH, Korsmeyer SJ, Heerema NA, et al. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood. 1993;81(9):2386-93.
    • (1993) Blood , vol.81 , Issue.9 , pp. 2386-2393
    • Chen, C.S.1    Sorensen, P.H.2    Domer, P.H.3    Reaman, G.H.4    Korsmeyer, S.J.5    Heerema, N.A.6    Hammond, G.D.7    Kersey, J.H.8
  • 57
    • 0028978125 scopus 로고
    • ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children
    • 1:CAS:528:DyaK2MXlvFegsr8%3D 7756657
    • Felix CA, Hosler MR, Winick NJ, Masterson M, Wilson AE, Lange BJ. ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Blood. 1995;85(11):3250-6.
    • (1995) Blood , vol.85 , Issue.11 , pp. 3250-3256
    • Felix, C.A.1    Hosler, M.R.2    Winick, N.J.3    Masterson, M.4    Wilson, A.E.5    Lange, B.J.6
  • 60
    • 0026496887 scopus 로고
    • The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene
    • 1:CAS:528:DyaK3sXlslaltQ%3D%3D 1423625
    • Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G, et al. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell. 1992;71(4):701-8.
    • (1992) Cell , vol.71 , Issue.4 , pp. 701-708
    • Gu, Y.1    Nakamura, T.2    Alder, H.3    Prasad, R.4    Canaani, O.5    Cimino, G.6    Croce, C.M.7    Canaani, E.8
  • 61
    • 0026454451 scopus 로고
    • Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias
    • 1:CAS:528:DyaK3sXkvFantLk%3D 1423624
    • Tkachuk DC, Kohler S, Cleary ML. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell. 1992;71(4):691-700.
    • (1992) Cell , vol.71 , Issue.4 , pp. 691-700
    • Tkachuk, D.C.1    Kohler, S.2    Cleary, M.L.3
  • 62
    • 0030905542 scopus 로고    scopus 로고
    • The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures
    • 1:CAS:528:DyaK2sXivVyls70%3D 9129043
    • Butler LH, Slany R, Cui X, Cleary ML, Mason DY. The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures. Blood. 1997;89(9):3361-70.
    • (1997) Blood , vol.89 , Issue.9 , pp. 3361-3370
    • Butler, L.H.1    Slany, R.2    Cui, X.3    Cleary, M.L.4    Mason, D.Y.5
  • 63
    • 0035893240 scopus 로고    scopus 로고
    • Histone H3 lysine 4 methylation is mediated by Set1 and required for cell growth and rDNA silencing in Saccharomyces cerevisiae
    • 1:CAS:528:DC%2BD38XivFykuw%3D%3D 11751634 312847
    • Briggs SD, Bryk M, Strahl BD, Cheung WL, Davie JK, Dent SY, et al. Histone H3 lysine 4 methylation is mediated by Set1 and required for cell growth and rDNA silencing in Saccharomyces cerevisiae. Genes Dev. 2001;15(24):3286-95.
    • (2001) Genes Dev , vol.15 , Issue.24 , pp. 3286-3295
    • Briggs, S.D.1    Bryk, M.2    Strahl, B.D.3    Cheung, W.L.4    Davie, J.K.5    Dent, S.Y.6    Winston, F.7    Allis, C.D.8
  • 64
    • 18744373853 scopus 로고    scopus 로고
    • MLL targets SET domain methyltransferase activity to Hox gene promoters
    • 1:CAS:528:DC%2BD38Xptl2ksb0%3D 12453418
    • Milne TA, Briggs SD, Brock HW, Martin ME, Gibbs D, Allis CD, et al. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell. 2002;10(5):1107-17.
    • (2002) Mol Cell , vol.10 , Issue.5 , pp. 1107-1117
    • Milne, T.A.1    Briggs, S.D.2    Brock, H.W.3    Martin, M.E.4    Gibbs, D.5    Allis, C.D.6    Hess, J.L.7
  • 65
    • 0035839952 scopus 로고    scopus 로고
    • Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins
    • 1:CAS:528:DC%2BD3MXnt12gtbo%3D 11607819
    • Ayton PM, Cleary ML. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene. 2001;20(40):5695-707.
    • (2001) Oncogene , vol.20 , Issue.40 , pp. 5695-5707
    • Ayton, P.M.1    Cleary, M.L.2
  • 70
    • 84866845694 scopus 로고    scopus 로고
    • Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L
    • 1:CAS:528:DC%2BC38Xht1KjsrjO 22924785 3475323
    • Anglin JL, Deng L, Yao Y, Cai G, Liu Z, Jiang H, et al. Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L. J Med Chem. 2012;55(18):8066-74.
    • (2012) J Med Chem , vol.55 , Issue.18 , pp. 8066-8074
    • Anglin, J.L.1    Deng, L.2    Yao, Y.3    Cai, G.4    Liu, Z.5    Jiang, H.6    Cheng, G.7    Chen, P.8    Dong, S.9    Song, Y.10
  • 71
    • 80055019988 scopus 로고    scopus 로고
    • Selective inhibitors of histone methyltransferase DOT1L: Design, synthesis, and crystallographic studies
    • 1:CAS:528:DC%2BC3MXht1Oju7jI 21936531 3492951
    • Yao Y, Chen P, Diao J, Cheng G, Deng L, Anglin JL, et al. Selective inhibitors of histone methyltransferase DOT1L: design, synthesis, and crystallographic studies. J Am Chem Soc. 2011;133(42):16746-9.
    • (2011) J Am Chem Soc , vol.133 , Issue.42 , pp. 16746-16749
    • Yao, Y.1    Chen, P.2    Diao, J.3    Cheng, G.4    Deng, L.5    Anglin, J.L.6    Prasad, B.V.7    Song, Y.8
  • 74
    • 84901406956 scopus 로고    scopus 로고
    • DOT1L inhibition sensitizes MLL-rearranged AML to chemotherapy
    • 24858818 4032273
    • Liu W, Deng L, Song Y, Redell M. DOT1L inhibition sensitizes MLL-rearranged AML to chemotherapy. PLoS One. 2014;9(5):e98270.
    • (2014) PLoS One , vol.9 , Issue.5 , pp. e98270
    • Liu, W.1    Deng, L.2    Song, Y.3    Redell, M.4
  • 75
    • 84877312453 scopus 로고    scopus 로고
    • Synthesis, Activity and Metabolic Stability of Non-Ribose Containing Inhibitors of Histone Methyltransferase DOT1L
    • 1:CAS:528:DC%2BC3sXmvVygs7o%3D
    • Deng L, Zhang L, Yao Y, Wang C, Redell MS, Dong S, et al. Synthesis, Activity and Metabolic Stability of Non-Ribose Containing Inhibitors of Histone Methyltransferase DOT1L. Med Chem Commun. 2013;4(5):822-6.
    • (2013) Med Chem Commun , vol.4 , Issue.5 , pp. 822-826
    • Deng, L.1    Zhang, L.2    Yao, Y.3    Wang, C.4    Redell, M.S.5    Dong, S.6    Song, Y.7
  • 78
    • 84916897484 scopus 로고    scopus 로고
    • Inhibition of histone H3K79 methylation selectively inhibits proliferation, self-renewal and metastatic potential of breast cancer
    • 25359765 4279401
    • Zhang L, Deng L, Chen F, Yao Y, Wu B, Wei L, et al. Inhibition of histone H3K79 methylation selectively inhibits proliferation, self-renewal and metastatic potential of breast cancer. Oncotarget. 2014;5(21):10665-77.
    • (2014) Oncotarget , vol.5 , Issue.21 , pp. 10665-10677
    • Zhang, L.1    Deng, L.2    Chen, F.3    Yao, Y.4    Wu, B.5    Wei, L.6    Mo, Q.7    Song, Y.8
  • 79
    • 84863115862 scopus 로고    scopus 로고
    • Deficiency of H3K79 histone methyltransferase Dot1-like protein (DOT1L) inhibits cell proliferation
    • 1:CAS:528:DC%2BC38XisVyltLo%3D 22190683
    • Kim W, Kim R, Park G, Park JW, Kim JE. Deficiency of H3K79 histone methyltransferase Dot1-like protein (DOT1L) inhibits cell proliferation. J Biol Chem. 2012;287(8):5588-99.
    • (2012) J Biol Chem , vol.287 , Issue.8 , pp. 5588-5599
    • Kim, W.1    Kim, R.2    Park, G.3    Park, J.W.4    Kim, J.E.5
  • 82
    • 0028091804 scopus 로고
    • 11q23 translocations split the aT-hook cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene
    • 1:CAS:528:DyaK2cXmslOkurc%3D 7938000 45071
    • Zeleznik-Le NJ, Harden AM, Rowley JD. 11q23 translocations split the AT-hook cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene. Proc Natl Acad Sci U S A. 1994;91(22):10610-4.
    • (1994) Proc Natl Acad Sci U S A , vol.91 , Issue.22 , pp. 10610-10614
    • Zeleznik-Le, N.J.1    Harden, A.M.2    Rowley, J.D.3
  • 83
    • 18744366334 scopus 로고    scopus 로고
    • Hox regulation of normal and leukemic hematopoietic stem cells
    • 1:CAS:528:DC%2BD2MXktlyisbw%3D 15867577
    • Abramovich C, Humphries RK. Hox regulation of normal and leukemic hematopoietic stem cells. Curr Opin Hematol. 2005;12(3):210-6.
    • (2005) Curr Opin Hematol , vol.12 , Issue.3 , pp. 210-216
    • Abramovich, C.1    Humphries, R.K.2
  • 85
    • 33745862395 scopus 로고    scopus 로고
    • Crystal structure and mechanism of human lysine-specific demethylase-1
    • 1:CAS:528:DC%2BD28Xms1eltLs%3D 16799558
    • Stavropoulos P, Blobel G, Hoelz A. Crystal structure and mechanism of human lysine-specific demethylase-1. Nat Struct Mol Biol. 2006;13(7):626-32.
    • (2006) Nat Struct Mol Biol , vol.13 , Issue.7 , pp. 626-632
    • Stavropoulos, P.1    Blobel, G.2    Hoelz, A.3
  • 89
    • 84879286937 scopus 로고    scopus 로고
    • The lasting influence of LSD1 in the blood
    • 23795303 3687340
    • Dent SY, Chandra J. The lasting influence of LSD1 in the blood. eLife. 2013;2:e00963.
    • (2013) ELife , vol.2 , pp. e00963
    • Dent, S.Y.1    Chandra, J.2
  • 90
    • 84869455559 scopus 로고    scopus 로고
    • LSD1 inhibition: A therapeutic strategy in cancer?
    • 1:CAS:528:DC%2BC38Xhs12jtrzI 22957941
    • Lynch JT, Harris WJ, Somervaille TC. LSD1 inhibition: a therapeutic strategy in cancer? Expert Opin Ther Targets. 2012;16(12):1239-49.
    • (2012) Expert Opin Ther Targets , vol.16 , Issue.12 , pp. 1239-1249
    • Lynch, J.T.1    Harris, W.J.2    Somervaille, T.C.3
  • 101
    • 77950868547 scopus 로고    scopus 로고
    • Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology
    • 1:CAS:528:DC%2BC3cXivFGmsrw%3D 20042638
    • Lim S, Janzer A, Becker A, Zimmer A, Schule R, Buettner R, et al. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis. 2010;31(3):512-20.
    • (2010) Carcinogenesis , vol.31 , Issue.3 , pp. 512-520
    • Lim, S.1    Janzer, A.2    Becker, A.3    Zimmer, A.4    Schule, R.5    Buettner, R.6    Kirfel, J.7
  • 105
    • 84890448100 scopus 로고    scopus 로고
    • High-throughput virtual screening identifies novel N'-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors
    • 1:CAS:528:DC%2BC3sXhslyks7fF 24237195
    • Sorna V, Theisen ER, Stephens B, Warner SL, Bearss DJ, Vankayalapati H, et al. High-throughput virtual screening identifies novel N'-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors. J Med Chem. 2013;56(23):9496-508.
    • (2013) J Med Chem , vol.56 , Issue.23 , pp. 9496-9508
    • Sorna, V.1    Theisen, E.R.2    Stephens, B.3    Warner, S.L.4    Bearss, D.J.5    Vankayalapati, H.6    Sharma, S.7
  • 107
    • 84922288173 scopus 로고    scopus 로고
    • Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells
    • 1:CAS:528:DC%2BC2cXntlaqurk%3D 24699304 4739780
    • Fiskus W, Sharma S, Shah B, Portier BP, Devaraj SG, Liu K, et al. Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells. Leukemia. 2014;28(11):2155-64.
    • (2014) Leukemia , vol.28 , Issue.11 , pp. 2155-2164
    • Fiskus, W.1    Sharma, S.2    Shah, B.3    Portier, B.P.4    Devaraj, S.G.5    Liu, K.6    Iyer, S.P.7    Bearss, D.8    Bhalla, K.N.9
  • 109
    • 34249934238 scopus 로고    scopus 로고
    • Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes
    • 1:CAS:528:DC%2BD2sXmtFCiurg%3D 17463086 1857229
    • Huang Y, Greene E, Murray Stewart T, Goodwin AC, Baylin SB, Woster PM, et al. Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes. Proc Natl Acad Sci U S A. 2007;104(19):8023-8.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , Issue.19 , pp. 8023-8028
    • Huang, Y.1    Greene, E.2    Murray Stewart, T.3    Goodwin, A.C.4    Baylin, S.B.5    Woster, P.M.6    Casero, R.A.7
  • 110
    • 77954691054 scopus 로고    scopus 로고
    • (Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators
    • 1:CAS:528:DC%2BC3cXnvVKqsbo%3D 20568780 2920492
    • Sharma SK, Wu Y, Steinbergs N, Crowley ML, Hanson AS, Casero RA, et al. (Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators. J Med Chem. 2010;53(14):5197-212.
    • (2010) J Med Chem , vol.53 , Issue.14 , pp. 5197-5212
    • Sharma, S.K.1    Wu, Y.2    Steinbergs, N.3    Crowley, M.L.4    Hanson, A.S.5    Casero, R.A.6    Woster, P.M.7
  • 112
    • 84955305423 scopus 로고    scopus 로고
    • 3-(Piperidin-4-ylmethoxy)pyridine Containing Compounds Are Potent Inhibitors of Lysine Specific Demethylase 1
    • 1:CAS:528:DC%2BC2MXhvFylu77N 26652247
    • Wu F, Zhou C, Yao Y, Wei L, Feng Z, Deng L, et al. 3-(Piperidin-4-ylmethoxy)pyridine Containing Compounds Are Potent Inhibitors of Lysine Specific Demethylase 1. J Med Chem. 2016;59(1):253-63.
    • (2016) J Med Chem , vol.59 , Issue.1 , pp. 253-263
    • Wu, F.1    Zhou, C.2    Yao, Y.3    Wei, L.4    Feng, Z.5    Deng, L.6    Song, Y.7
  • 113
    • 84055211870 scopus 로고    scopus 로고
    • Lysine demethylases inhibitors
    • 1:CAS:528:DC%2BC3MXht1OrtrnF 21955276
    • Suzuki T, Miyata N. Lysine demethylases inhibitors. J Med Chem. 2011;54(24):8236-50.
    • (2011) J Med Chem , vol.54 , Issue.24 , pp. 8236-8250
    • Suzuki, T.1    Miyata, N.2
  • 115
    • 78649509903 scopus 로고    scopus 로고
    • An Ash2L/RbBP5 heterodimer stimulates the MLL1 methyltransferase activity through coordinated substrate interactions with the MLL1 SET domain
    • 21124902 2990719
    • Cao F, Chen Y, Cierpicki T, Liu Y, Basrur V, Lei M, et al. An Ash2L/RbBP5 heterodimer stimulates the MLL1 methyltransferase activity through coordinated substrate interactions with the MLL1 SET domain. PLoS One. 2010;5(11):e14102.
    • (2010) PLoS One , vol.5 , Issue.11 , pp. e14102
    • Cao, F.1    Chen, Y.2    Cierpicki, T.3    Liu, Y.4    Basrur, V.5    Lei, M.6    Dou, Y.7
  • 117
    • 84872531591 scopus 로고    scopus 로고
    • High-affinity, small-molecule peptidomimetic inhibitors of MLL1/WDR5 protein-protein interaction
    • 1:CAS:528:DC%2BC38XhslOlsbvO 23210835
    • Karatas H, Townsend EC, Cao F, Chen Y, Bernard D, Liu L, et al. High-affinity, small-molecule peptidomimetic inhibitors of MLL1/WDR5 protein-protein interaction. J Am Chem Soc. 2013;135(2):669-82.
    • (2013) J Am Chem Soc , vol.135 , Issue.2 , pp. 669-682
    • Karatas, H.1    Townsend, E.C.2    Cao, F.3    Chen, Y.4    Bernard, D.5    Liu, L.6    Lei, M.7    Dou, Y.8    Wang, S.9
  • 120
    • 0037111831 scopus 로고    scopus 로고
    • Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein
    • 1:CAS:528:DC%2BD38XovVejsLY%3D 12435631 187479
    • Kuzmichev A, Nishioka K, Erdjument-Bromage H, Tempst P, Reinberg D. Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev. 2002;16(22):2893-905.
    • (2002) Genes Dev , vol.16 , Issue.22 , pp. 2893-2905
    • Kuzmichev, A.1    Nishioka, K.2    Erdjument-Bromage, H.3    Tempst, P.4    Reinberg, D.5
  • 121
    • 0032076718 scopus 로고    scopus 로고
    • Polycombing the genome: PcG, trxG, and chromatin silencing
    • 1:CAS:528:DyaK1cXjtFCjtL8%3D 9590168
    • Pirrotta V. Polycombing the genome: PcG, trxG, and chromatin silencing. Cell. 1998;93(3):333-6.
    • (1998) Cell , vol.93 , Issue.3 , pp. 333-336
    • Pirrotta, V.1
  • 122
    • 0035380103 scopus 로고    scopus 로고
    • Mechanisms of transcriptional memory
    • 1:CAS:528:DC%2BD3MXks1agsrs%3D 11389465
    • Francis NJ, Kingston RE. Mechanisms of transcriptional memory. Nat Rev Mol Cell Biol. 2001;2(6):409-21.
    • (2001) Nat Rev Mol Cell Biol , vol.2 , Issue.6 , pp. 409-421
    • Francis, N.J.1    Kingston, R.E.2
  • 123
    • 0036532114 scopus 로고    scopus 로고
    • Programming off and on states in chromatin: Mechanisms of Polycomb and trithorax group complexes
    • 1:CAS:528:DC%2BD38XhvVCnsbc%3D 11893495
    • Simon JA, Tamkun JW. Programming off and on states in chromatin: mechanisms of Polycomb and trithorax group complexes. Curr Opin Genet Dev. 2002;12(2):210-8.
    • (2002) Curr Opin Genet Dev , vol.12 , Issue.2 , pp. 210-218
    • Simon, J.A.1    Tamkun, J.W.2
  • 124
    • 3042801308 scopus 로고    scopus 로고
    • SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex
    • 1:CAS:528:DC%2BD2cXlvFejurc%3D 15225548
    • Cao R, Zhang Y. SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol Cell. 2004;15(1):57-67.
    • (2004) Mol Cell , vol.15 , Issue.1 , pp. 57-67
    • Cao, R.1    Zhang, Y.2
  • 125
    • 8144230178 scopus 로고    scopus 로고
    • Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity
    • 1:CAS:528:DC%2BD2cXotlCrs74%3D 15385962 524339
    • Pasini D, Bracken AP, Jensen MR, Lazzerini Denchi E, Helin K. Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J. 2004;23(20):4061-71.
    • (2004) EMBO J , vol.23 , Issue.20 , pp. 4061-4071
    • Pasini, D.1    Bracken, A.P.2    Jensen, M.R.3    Lazzerini Denchi, E.4    Helin, K.5
  • 126
    • 84864072835 scopus 로고    scopus 로고
    • Polycomb genes and cancer: Time for clinical application?
    • 22112692
    • Crea F, Paolicchi E, Marquez VE, Danesi R. Polycomb genes and cancer: time for clinical application? Crit Rev Oncol Hematol. 2012;83(2):184-93.
    • (2012) Crit Rev Oncol Hematol , vol.83 , Issue.2 , pp. 184-193
    • Crea, F.1    Paolicchi, E.2    Marquez, V.E.3    Danesi, R.4
  • 130
    • 84954430798 scopus 로고    scopus 로고
    • Prognostic Significance of EZH2 Expression in Non-Small Cell Lung Cancer: A Meta-analysis
    • 1:CAS:528:DC%2BC28Xos1emtw%3D%3D 26754405 4709684
    • Wang X, Zhao H, Lv L, Bao L, Han S. Prognostic Significance of EZH2 Expression in Non-Small Cell Lung Cancer: A Meta-analysis. Scientific reports. 2016;6:19239.
    • (2016) Scientific Reports , vol.6 , pp. 19239
    • Wang, X.1    Zhao, H.2    Lv, L.3    Bao, L.4    Han, S.5
  • 132
    • 55949136562 scopus 로고    scopus 로고
    • Roles of the EZH2 histone methyltransferase in cancer epigenetics
    • 1:CAS:528:DC%2BD1cXhtlyks7nP 18723033
    • Simon JA, Lange CA. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res. 2008;647(1-2):21-9.
    • (2008) Mutat Res , vol.647 , Issue.1-2 , pp. 21-29
    • Simon, J.A.1    Lange, C.A.2
  • 135
    • 29344439946 scopus 로고    scopus 로고
    • Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas
    • 1:CAS:528:DC%2BD2MXnslykurs%3D 16012774
    • Weikert S, Christoph F, Kollermann J, Muller M, Schrader M, Miller K, et al. Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas. Int J Mol Med. 2005;16(2):349-53.
    • (2005) Int J Mol Med , vol.16 , Issue.2 , pp. 349-353
    • Weikert, S.1    Christoph, F.2    Kollermann, J.3    Muller, M.4    Schrader, M.5    Miller, K.6    Krause, H.7
  • 136
    • 84874106911 scopus 로고    scopus 로고
    • The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia
    • 1:CAS:528:DC%2BC38XkvVGku7w%3D 22469984
    • Shi J, Wang E, Zuber J, Rappaport A, Taylor M, Johns C, et al. The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia. Oncogene. 2013;32(7):930-8.
    • (2013) Oncogene , vol.32 , Issue.7 , pp. 930-938
    • Shi, J.1    Wang, E.2    Zuber, J.3    Rappaport, A.4    Taylor, M.5    Johns, C.6    Lowe, S.W.7    Vakoc, C.R.8
  • 143
    • 78650454078 scopus 로고    scopus 로고
    • Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas
    • 1:CAS:528:DC%2BC3cXhsFyrsbnF 21078963 3000297
    • Sneeringer CJ, Scott MP, Kuntz KW, Knutson SK, Pollock RM, Richon VM, et al. Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas. Proc Natl Acad Sci U S A. 2010;107(49):20980-5.
    • (2010) Proc Natl Acad Sci U S A , vol.107 , Issue.49 , pp. 20980-20985
    • Sneeringer, C.J.1    Scott, M.P.2    Kuntz, K.W.3    Knutson, S.K.4    Pollock, R.M.5    Richon, V.M.6    Copeland, R.A.7
  • 145
    • 80053279825 scopus 로고    scopus 로고
    • The Y641C mutation of EZH2 alters substrate specificity for histone H3 lysine 27 methylation states
    • 1:CAS:528:DC%2BC3MXht1ejurvK 21856302
    • Wigle TJ, Knutson SK, Jin L, Kuntz KW, Pollock RM, Richon VM, et al. The Y641C mutation of EZH2 alters substrate specificity for histone H3 lysine 27 methylation states. FEBS Lett. 2011;585(19):3011-4.
    • (2011) FEBS Lett , vol.585 , Issue.19 , pp. 3011-3014
    • Wigle, T.J.1    Knutson, S.K.2    Jin, L.3    Kuntz, K.W.4    Pollock, R.M.5    Richon, V.M.6    Copeland, R.A.7    Scott, M.P.8
  • 150
    • 4043105583 scopus 로고    scopus 로고
    • Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity
    • 1:CAS:528:DC%2BD2cXmtFOhs70%3D 15173171
    • Xu X, Zhao J, Xu Z, Peng B, Huang Q, Arnold E, et al. Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity. J Biol Chem. 2004;279(32):33946-57.
    • (2004) J Biol Chem , vol.279 , Issue.32 , pp. 33946-33957
    • Xu, X.1    Zhao, J.2    Xu, Z.3    Peng, B.4    Huang, Q.5    Arnold, E.6    Ding, J.7
  • 151
    • 0027310324 scopus 로고
    • Function and expression of yeast mitochondrial NAD- and NADP-specific isocitrate dehydrogenases
    • 1:CAS:528:DyaK3sXksVCqtb8%3D 8099357
    • Haselbeck RJ, McAlister-Henn L. Function and expression of yeast mitochondrial NAD- and NADP-specific isocitrate dehydrogenases. J Biol Chem. 1993;268(16):12116-22.
    • (1993) J Biol Chem , vol.268 , Issue.16 , pp. 12116-12122
    • Haselbeck, R.J.1    McAlister-Henn, L.2
  • 161
    • 77956265489 scopus 로고    scopus 로고
    • IDH mutations in glioma and acute myeloid leukemia
    • 1:CAS:528:DC%2BC3cXhtFajs7zJ 20692206
    • Dang L, Jin S, Su SM. IDH mutations in glioma and acute myeloid leukemia. Trends Mol Med. 2010;16(9):387-97.
    • (2010) Trends Mol Med , vol.16 , Issue.9 , pp. 387-397
    • Dang, L.1    Jin, S.2    Su, S.M.3
  • 162
    • 78649990315 scopus 로고    scopus 로고
    • Cancer-associated IDH mutations: Biomarker and therapeutic opportunities
    • 1:CAS:528:DC%2BC3cXhtlahu7vO 20972461
    • Yen KE, Bittinger MA, Su SM, Fantin VR. Cancer-associated IDH mutations: biomarker and therapeutic opportunities. Oncogene. 2010;29(49):6409-17.
    • (2010) Oncogene , vol.29 , Issue.49 , pp. 6409-6417
    • Yen, K.E.1    Bittinger, M.A.2    Su, S.M.3    Fantin, V.R.4
  • 163
    • 65349150503 scopus 로고    scopus 로고
    • IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas
    • 1:CAS:528:DC%2BD1MXksVOksLY%3D 19246647 2671348
    • Watanabe T, Nobusawa S, Kleihues P, Ohgaki H. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol. 2009;174(4):1149-53.
    • (2009) Am J Pathol , vol.174 , Issue.4 , pp. 1149-1153
    • Watanabe, T.1    Nobusawa, S.2    Kleihues, P.3    Ohgaki, H.4
  • 174
    • 84879085295 scopus 로고    scopus 로고
    • Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase
    • 1:CAS:528:DC%2BC3sXntVWrtLg%3D 23795241 3686309
    • Zheng B, Yao Y, Liu Z, Deng L, Anglin JL, Jiang H, et al. Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase. ACS Med Chem Lett. 2013;4(6):542-6.
    • (2013) ACS Med Chem Lett , vol.4 , Issue.6 , pp. 542-546
    • Zheng, B.1    Yao, Y.2    Liu, Z.3    Deng, L.4    Anglin, J.L.5    Jiang, H.6    Prasad, B.V.7    Song, Y.8
  • 175
    • 84908388856 scopus 로고    scopus 로고
    • Inhibition of cancer-associated mutant isocitrate dehydrogenases: Synthesis, structure-activity relationship, and selective antitumor activity
    • 1:CAS:528:DC%2BC2cXhs1Khu7nF 25271760 4207540
    • Liu Z, Yao Y, Kogiso M, Zheng B, Deng L, Qiu JJ, et al. Inhibition of cancer-associated mutant isocitrate dehydrogenases: synthesis, structure-activity relationship, and selective antitumor activity. J Med Chem. 2014;57(20):8307-18.
    • (2014) J Med Chem , vol.57 , Issue.20 , pp. 8307-8318
    • Liu, Z.1    Yao, Y.2    Kogiso, M.3    Zheng, B.4    Deng, L.5    Qiu, J.J.6    Dong, S.7    Lv, H.8    Gallo, J.M.9    Li, X.N.10    Song, Y.11
  • 176
    • 84941578432 scopus 로고    scopus 로고
    • Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
    • 1:CAS:528:DC%2BC2MXhtlequ7nI 26280302
    • Wu F, Jiang H, Zheng B, Kogiso M, Yao Y, Zhou C, et al. Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds. J Med Chem. 2015;58(17):6899-908.
    • (2015) J Med Chem , vol.58 , Issue.17 , pp. 6899-6908
    • Wu, F.1    Jiang, H.2    Zheng, B.3    Kogiso, M.4    Yao, Y.5    Zhou, C.6    Li, X.N.7    Song, Y.8
  • 178
    • 84911906262 scopus 로고    scopus 로고
    • Role of PRMTs in cancer: Could minor isoforms be leaving a mark?
    • 24921003 4050107
    • Baldwin RM, Morettin A, Cote J. Role of PRMTs in cancer: Could minor isoforms be leaving a mark? World J Biol Chem. 2014;5(2):115-29.
    • (2014) World J Biol Chem , vol.5 , Issue.2 , pp. 115-129
    • Baldwin, R.M.1    Morettin, A.2    Cote, J.3
  • 179
    • 0037099413 scopus 로고    scopus 로고
    • G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis
    • 1:CAS:528:DC%2BD38Xls1Onurg%3D 12130538 186403
    • Tachibana M, Sugimoto K, Nozaki M, Ueda J, Ohta T, Ohki M, et al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 2002;16(14):1779-91.
    • (2002) Genes Dev , vol.16 , Issue.14 , pp. 1779-1791
    • Tachibana, M.1    Sugimoto, K.2    Nozaki, M.3    Ueda, J.4    Ohta, T.5    Ohki, M.6    Fukuda, M.7    Takeda, N.8    Niida, H.9    Kato, H.10    Shinkai, Y.11
  • 181
    • 44249128891 scopus 로고    scopus 로고
    • Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells
    • 18446223 2323574
    • Kondo Y, Shen L, Ahmed S, Boumber Y, Sekido Y, Haddad BR, et al. Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells. PLoS One. 2008;3(4):e2037.
    • (2008) PLoS One , vol.3 , Issue.4 , pp. e2037
    • Kondo, Y.1    Shen, L.2    Ahmed, S.3    Boumber, Y.4    Sekido, Y.5    Haddad, B.R.6    Issa, J.P.7
  • 200
    • 84978023495 scopus 로고    scopus 로고
    • Phenethyl isothiocyanate and paclitaxel synergistically enhanced apoptosis and alpha-tubulin hyperacetylation in breast cancer cells
    • 24495785 3927854
    • Cang S, Ma Y, Chiao JW, Liu D. Phenethyl isothiocyanate and paclitaxel synergistically enhanced apoptosis and alpha-tubulin hyperacetylation in breast cancer cells. Exp Hematol Oncol. 2014;3(1):5.
    • (2014) Exp Hematol Oncol , vol.3 , Issue.1 , pp. 5
    • Cang, S.1    Ma, Y.2    Chiao, J.W.3    Liu, D.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.